Summary for Patients: Bleeding Risk During Extended Anticoagulant Therapy for Venous Thromboembolism | Annals of Internal Medicine
What is the problem and what is known about it so far?Although some patients who develop blood clots called venous thromboembolisms may have clear risk factors, some of these events are considered unprovoked, with no clear reason why the clot formed. In these cases, guidelines recommend treating with anticoagulation for at least 3 months. Decisions about longer courses need to consider the…
